Search

everythinglearnresearchcommunity

for

Search:↓

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.

Finasteride effectively treats hair loss and prostate issues with minimal side effects.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Finasteride for hair loss has minimal impact on sexual function.

Early hair loss may indicate prostate issues.

Ganoderma lucidum may help treat enlarged prostate in rats.

Early hair loss may indicate future prostate issues.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Urinary PSA could be an early marker for enlarged prostate.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

α-spinasterol from Melandrium firmum can help reduce prostate enlargement.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.